What a ride, although the stock is in a trading halt, the team...

What a ride, although the stock is in a trading halt, the team just keeps on working and thinking of different ways to take this new strategy forward.

This latest announcement will in my opinion achieve a far better outcome than the previously annnounced Medcan deal. Well done to Sholom, got to give credit where credit is due.

The extend half is a huge inconvenience, but for long term investors, so what. If you were in here for a quick buck, that’s unfortunate.

Patience everyone, this may be a mega bagger in the making.